Zurich Cantonal Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.8K | Buy |
+3,079
| New | +$12.6K | ﹤0.01% | 2480 |
|
|
2025
Q2 | – | Sell |
-35,702
| Closed | -$52.5K | – | 2598 |
|
|
2025
Q1 | $52.5K | Sell |
35,702
-39
| -0.1% | -$93 | ﹤0.01% | 2510 |
|
|
2024
Q4 | $158K | Sell |
35,741
-1,700
| -5% | -$6.9K | ﹤0.01% | 2254 |
|
|
2024
Q3 | $154K | Sell |
37,441
-4,390
| -10% | -$23.6K | ﹤0.01% | 2246 |
|
|
2024
Q2 | $273K | Buy |
41,831
+4,016
| +11% | +$28.4K | ﹤0.01% | 1885 |
|
|
2024
Q1 | $329K | Buy |
37,815
+5,094
| +16% | +$61.8K | ﹤0.01% | 1752 |
|
|
2023
Q4 | $374K | Buy |
32,721
+5,318
| +19% | +$52.6K | ﹤0.01% | 1697 |
|
|
2023
Q3 | $264K | Sell |
27,403
-412
| -1% | -$4.04K | ﹤0.01% | 1797 |
|
|
2023
Q2 | $296K | Sell |
27,815
-376
| -1% | -$4.04K | ﹤0.01% | 1682 |
|
|
2023
Q1 | $297K | Buy |
28,191
+9,826
| +54% | +$110K | ﹤0.01% | 1629 |
|
|
2022
Q4 | $228K | Sell |
18,365
-1,056
| -5% | -$12K | ﹤0.01% | 1750 |
|
|
2022
Q3 | $201K | Hold |
19,421
| – | – | ﹤0.01% | 1755 |
|
|
2022
Q2 | $224K | Hold |
19,421
| – | – | ﹤0.01% | 1723 |
|
|
2022
Q1 | $244K | Hold |
19,421
| – | – | ﹤0.01% | 1768 |
|
|
2021
Q4 | $226K | Hold |
19,421
| – | – | ﹤0.01% | 1991 |
|
|
2021
Q3 | $254K | Hold |
19,421
| – | – | ﹤0.01% | 1763 |
|
|
2021
Q2 | $250K | Hold |
19,421
| – | – | ﹤0.01% | 1667 |
|
|
2021
Q1 | $217K | Sell |
19,421
-3,467
| -15% | -$36.6K | ﹤0.01% | 1730 |
|
|
2020
Q4 | $261K | Buy |
22,888
+3,603
| +19% | +$39.4K | ﹤0.01% | 1673 |
|
|
2020
Q3 | $173K | Hold |
19,285
| – | – | ﹤0.01% | 1707 |
|
|
2020
Q2 | $199K | Buy |
19,285
+3,441
| +22% | +$35.2K | ﹤0.01% | 1526 |
|
|
2020
Q1 | $160K | Buy |
15,844
+5,524
| +54% | +$64.9K | ﹤0.01% | 1332 |
|
|
2019
Q4 | $137K | Buy |
10,320
+1,868
| +22% | +$20.6K | ﹤0.01% | 1538 |
|
|
2019
Q3 | $73K | Hold |
8,452
| – | – | ﹤0.01% | 1784 |
|
|
2019
Q2 | $92K | Sell |
8,452
-1,640
| -16% | -$18.4K | ﹤0.01% | 1673 |
|
|
2019
Q1 | $114K | Sell |
10,092
-1,910
| -16% | -$21.3K | ﹤0.01% | 1504 |
|
|
2018
Q4 | $104K | Hold |
12,002
| – | – | ﹤0.01% | 1583 |
|
|
2018
Q3 | $186K | Buy |
12,002
+1,244
| +12% | +$19.7K | ﹤0.01% | 1343 |
|
|
2018
Q2 | $172K | Hold |
10,758
| – | – | ﹤0.01% | 1331 |
|
|
2018
Q1 | $139K | Hold |
10,758
| – | – | ﹤0.01% | 1418 |
|
|
2017
Q4 | $135K | Buy |
10,758
+6,052
| +129% | +$79K | ﹤0.01% | 1423 |
|
|
2017
Q3 | $62K | Hold |
4,706
| – | – | ﹤0.01% | 1666 |
|
|
2017
Q2 | $74K | Buy |
4,706
+722
| +18% | +$10.5K | ﹤0.01% | 1533 |
|
|
2017
Q1 | $57K | Hold |
3,984
| – | – | ﹤0.01% | 1668 |
|
|
2016
Q4 | $51K | Hold |
3,984
| – | – | ﹤0.01% | 1684 |
|
|
2016
Q3 | $53K | Buy |
3,984
+594
| +18% | +$6.94K | ﹤0.01% | 1600 |
|
|
2016
Q2 | $37K | Hold |
3,390
| – | – | ﹤0.01% | 1655 |
|
|
2016
Q1 | $31K | Hold |
3,390
| – | – | ﹤0.01% | 1716 |
|
|
2015
Q4 | $33K | Buy |
3,390
+1,678
| +98% | +$16.2K | ﹤0.01% | 1698 |
|
|
2015
Q3 | $15K | Buy |
1,712
+827
| +93% | +$7.72K | ﹤0.01% | 1638 |
|
|
2015
Q2 | $9K | Hold |
885
| – | – | ﹤0.01% | 1446 |
|
|
2015
Q1 | $12K | Buy |
+885
| New | +$11.6K | ﹤0.01% | 1273 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Zurich Cantonal Bank's IRWD Position: Q1 2026 in Review
Zurich Cantonal Bank opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 3,079 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #2480 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in IRWD as recently as Q1 2025.
Zurich Cantonal Bank first reported a position in IRWD in Q1 2015 and has held it in 42 quarters since. The position peaked at $374K in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Zurich Cantonal Bank held 3,079 shares of Ironwood Pharmaceuticals worth $10.8K as of Q1 2026.
- Ironwood Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2480 holding.
- Zurich Cantonal Bank first reported a position in Ironwood Pharmaceuticals in Q1 2015 and has held it in 42 quarters since.
- Zurich Cantonal Bank's Ironwood Pharmaceuticals position peaked at $374K in Q4 2023.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.